Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiguo Chu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|October 25, 2013
TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapyChan Gao, Anna Kozlowska, Sergey Nechaev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2014
Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNAKeqiang Zhang, Hanlin Gao, Xiwei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responsesNicola R Hardwick, Mary Carroll, Teodora Kaltcheva, et al.
Autophagy|June 30, 2018
Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesisH Helen Lin, Yiyin Chung, Chun-Ting Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2017
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR<sup>+</sup>/HER2<sup>+</sup> Breast Cancer Patient-Derived Xenografts to Trastuzumab or FulvestrantPei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya, et al.
Clinical Science (London, England : 1979)|November 2, 2012
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancersXiyong Liu, Hang Zhang, Lily Lai, et al.
The Journal of Pathology|August 7, 2010
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migrationShi-Lu Luan, Emmanuelle Boulanger, Hongtao Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapyGeorge Somlo, Paul Frankel, Warren Chow, et al.
Journal of Clinical Medicine|October 23, 2019
Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRASArjun Kalvala, Pierre Wallet, Lu Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2011
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancersXiaochen Wang, Xiyong Liu, Angela Ying-Jian Li, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|October 25, 2013
TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapyChan Gao, Anna Kozlowska, Sergey Nechaev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2014
Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNAKeqiang Zhang, Hanlin Gao, Xiwei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responsesNicola R Hardwick, Mary Carroll, Teodora Kaltcheva, et al.
Autophagy|June 30, 2018
Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesisH Helen Lin, Yiyin Chung, Chun-Ting Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2017
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR<sup>+</sup>/HER2<sup>+</sup> Breast Cancer Patient-Derived Xenografts to Trastuzumab or FulvestrantPei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya, et al.
Clinical Science (London, England : 1979)|November 2, 2012
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancersXiyong Liu, Hang Zhang, Lily Lai, et al.
The Journal of Pathology|August 7, 2010
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migrationShi-Lu Luan, Emmanuelle Boulanger, Hongtao Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapyGeorge Somlo, Paul Frankel, Warren Chow, et al.
Journal of Clinical Medicine|October 23, 2019
Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRASArjun Kalvala, Pierre Wallet, Lu Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2011
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancersXiaochen Wang, Xiyong Liu, Angela Ying-Jian Li, et al.
Pageof 7